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Abstract Exposure of U937 cells to tert-butylhydroperoxide
(tB-OOH) led to cyclosporin A-sensitive mitochondrial mem-
brane permeability transition and necrosis. Pyruvate and
rotenone, which increase mitochondrial NADH via different
mechanisms, prevented these responses and the cells which
received these treatments proliferated with kinetics similar to
those observed in untreated cells. In contrast with these results,
cells rescued by cyclosporin A were unable to proliferate. Thus,
mitochondrial NADH plays a pivotal role in preventing upstream
events which result in the onset of mitochondrial membrane
permeability transition and death in cells exposed to tB-OOH.
These events appear to be critical for recovery of the ability of
the cells to proliferate.
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1. Introduction
Exposure of cultured mammalian cells to tert-butylhydro-
peroxide (tB-OOH) promotes an array of toxic events such as
depletion of glutathione [1,2], oxidation of pyridine nucleo-
tides [3,4], peroxidation of membrane lipids [5], perturbation
of calcium ion sequestration [4], DNA single strand breakage
[6^9], inhibition of glycolytic and non-glycolytic ATP synthe-
sis [10^13] and mitochondrial dysfunction [10,12,14^16]. It is
now generally accepted that the latter e¡ect plays a pivotal
role in the lethal response to a high concentration of tB-OOH
since cyclosporin A, an agent which binds to cyclophillin [17],
prevents the opening of permeability transition pores as well
as the lethal response [12].
We previously reported that U937 cell death caused by a
tB-OOH-induced loss of mitochondrial membrane potential
and permeability transition is dependent upon the availability
of intramitochondrial NADH [18]. Indeed, the lethal response
evoked by the hydroperoxide was prevented by NADH-linked
substrates (e.g. pyruvate of L-hydroxybutyrate) promoting mi-
tochondrial formation of NADH or by the complex I inhib-
itor rotenone, which enhances the mitochondrial content of
NADH by preventing its utilization in the respiratory chain.
In this study, we report that the mode of cell death asso-
ciated with the tB-OOH-dependent permeability transition is
necrosis and that its prevention mediated by either pyruvate
or rotenone is not followed by delayed apoptosis. Rather, the
cells surviving these treatments were able to proliferate with
kinetics superimposable to those of untreated cells. These re-
sults are in contrast with those observed in cells exposed to
cyclosporin A, which survived the treatment with tB-OOH but
did not recover their ability to proliferate.
2. Materials and methods
2.1. Cell culture and treatments
U937 cells were grown in RPMI 1640 culture medium (Gibco,
Grand Island, NY, USA) supplemented with 10% (v/v) fetal bovine
serum (Seralab, Sussex, UK), penicillin (50 U/ml) and streptomycin
(50 Wg/ml), at 37‡C in T-75 tissue culture £asks (Corning, NY, USA)
in an atmosphere of 95% air-5% Co2. Stock solutions of tB-OOH,
hydrogen peroxide, 3-aminobenzamide and pyruvate were freshly pre-
pared in saline A (0.14 M NaCl, 5 mM KCl, 4 mM NaHCO3),
rotenone was dissolved in 95% ethanol. At the treatment stage, the
¢nal ethanol concentration was never higher than 0.05%. Under these
conditions, ethanol was neither toxic nor did it a¡ect the cytotoxic
properties of tB-OOH.
Treatments were performed in saline A, both in the absence or
presence of glucose (5 mM). At the treatment stage, the cell density
was 2U105 cells/ml. Cells were used at a density of 1U105/ml only in
those experiments involving exposure to H2O2.
2.2. Cytotoxicity and growth inhibition assays
After the treatments, the cells were washed with ice-cold glucose-
contaning or -free saline A and resuspended in pre-warmed RPMI
1640 culture medium, plated into 35 mm tissue culture dishes and
incubated at 37‡C for di¡erent times. Cytotoxicity and growth inhib-
ition were determined using the trypan blue exclusion assay. Brie£y,
an aliquot of the cell suspension was diluted 1:1 (v/v) with 0.4%
trypan blue and the cells were counted using a haemocytometer. Re-
sults are expressed as the percentage of dead cells (ratio of stained
cells versus the total number of cells) or the viable cell number, re-
spectively.
2.3. DNA fragmentation analysis by programmable, autonomously
controlled electrodes (PACE) gel electrophoresis
Cells were embedded into agarose plugs as previously described
[19], except that the ¢nal cell density in the plugs was adjusted to
5U106/ml.
PACE electrophoresis was carried out using a Bio-Rad DR III
apparatus (Bio-Rad, Richmond, CA, USA). The gels were cast using
1% (w/v) pulsed ¢eld-grade agarose in 0.5UTris-borate-EDTA bu¡er
(44.5 mM Tris base, 44.5 mM boric acid, 1 mM EDTA, pH 8.3). The
switch time was linearly ramped from 10 to 70 s over 12 h of run time
at 150 V with a 120‡ reorientation angle. The temperature of the
running bu¡er (0.5UTris-borate-EDTA bu¡er) was maintained at
12‡C.
Gels were stained with ethidium bromide and photographed under
an UV transilluminator.
2.4. DNA fragmentation analysis by the ¢lter binding assay
Secondary DNA fragmentation was quanti¢ed using the ¢lter bind-
ing assay developed by Bertrand et al. [20]. DNA fragmentation was
determined as the fraction of the 3H-labelled DNA in the lysate plus
the EDTA wash versus total 3H-labelled DNA.
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3. Results and discussion
It is well known that the progression through necrotic or
apoptotic cell death is characterized by alterations in cell mor-
phology and speci¢c nuclear changes [21]. In particular, mi-
croscopic examination of morphological changes, in conjunc-
tion with the analysis of DNA fragmentation by pulsed ¢eld
and conventional gel electrophoresis, can provide information
about the mode of cell death. The morphological alterations
induced in U937 cells by a 30 min exposure to 1 mM tB-
OOH, followed by growth in fresh culture medium for 6 h,
were mainly represented by swelling of the cells followed by
loss of nuclear material (Fig. 1B), with no evidence of chro-
matin condensation or fragmentation. The onset of these mor-
phological changes occurred after 4 h of post-treatment incu-
bation (not shown). Conventional electrophoretic analysis of
the DNA from cells treated for 30 min with 1 mM tB-OOH
and then grown for 6 h in fresh medium indicated the absence
of internucleosomal DNA cleavage (not shown). Consistently,
no DNA fragmentation was detected (Fig. 1B). Analysis of
large DNA fragments by PACE gel electrophoresis revealed
that treatment with tB-OOH did not result in the formation of
the discrete, 50 kb paired DNA fragments which are produced
during apoptotic cell death [21^23], but rather generated the
smeared fragments which are indicative of necrotic cell death
[22]. Under these conditions, approximately 50% of the cells
had lost their ability to exclude trypan blue. When these cells
were grown for a further 12 h, the relative number of viable
cells increased and a much lower proportion of dead cells
could be detected in the culture medium, as a result of pro-
liferation of the undamaged cells and lysis of the damaged
cells. Most of these cells displayed a normal morphology
and DNA fragmentation was not detected using both the ¢lter
binding assay and PACE gel electrophoresis (Fig. 1B). These
results should be compared with those illustrated in Fig. 1A,
which were obtained using untreated cells. It was interesting
to observe that the biochemical and morphological parame-
ters measured in cells exposed to tB-OOH in the presence of
pyruvate (Fig. 1C) or rotenone (Fig. 1D) were similar to those
of untreated cells (Fig. 1A). Fig. 1C and D also shows that
tB-OOH was not toxic for pyruvate- or rotenone-supple-
mented cells after 6 h of post-treatment incubation and that
Fig. 1. The mode of cell death induced by tB-OOH is necrosis and its prevention promoted by pyruvate or rotenone does not lead U937 cells
into apoptosis. U937 cells (2U105/ml) were treated for 30 min in glucose-containing saline A with 1 mM tB-OOH in the absence (B) or pres-
ence of 5 mM pyruvate (C) or 0.5 WM rotenone (D) and then post-incubated in complete culture medium. After 6 and 18 h, the cells were pho-
tographed (400U magni¢cation), counted and analyzed for cell viability (by the trypan blue exclusion assay) or secondary DNA fragmentation
(using both the ¢lter binding assay and PACE electrophoresis). Also shown are the results obtained with untreated U937 cells (A) or cells
treated for 6 h with a combination of 1 mM H2O2 and 1 mM 3-aminobenzamide (E). Results shown in the bar graphs (samples taken after
6 h, open bars; samples taken after 18 h, striped bars) represent the mean þ S.E.M. of at least three separate determinations, each performed in
duplicate. The microphotographs and the gels are representatives of three experiments with similar outcomes.
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Fig. 2. Cell counts of U937 cells at various time intervals after
treatment with tB-OOH in the absence or presence of rotenone and
pyruvate. Cells were grown in liquid suspension culture after expo-
sure for 30 min in glucose-containing (A) or glucose-free (B) saline
A to 1 mM tB-OOH in the absence or presence of 5 mM pyruvate
or increasing concentrations of rotenone. Pyruvate or rotenone, at
the concentrations utilized in this study, did not a¡ect cell growth
(not shown). Results are presented as means of three experiments,
each performed in duplicate. Variation between experiments was less
than 5% and S.E.M.s were omitted for clarity.
Fig. 3. Acute lethal response and proliferation rate of U937 cells
after treatment with tB-OOH in the absence or presence of cyclo-
sporin A. U937 cells (2U105/ml) were treated for 30 min in glucose-
containing saline A with 1 mM tB-OOH, in the absence or presence
of 0.5 WM cyclosporin A, and then post-incubated in complete cul-
ture medium. The number of viable and dead cells was analyzed by
the trypan blue exclusion assay after increasing time intervals. In
(A), it is shown that cyclosporin A suppresses the acute (6 h post-
treatment incubation) lethal response evoked by tB-OOH. In (B), it
is shown that the cells rescued by cyclosporin A were unable to pro-
liferate. Results are presented as means of two separate experiments,
each performed in duplicate.
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the relative number of viable cells further increased after 12 h
of growth.
The results illustrated in Fig. 1E were obtained using U937
cells treated with the combination 1 mM H2O2/1 mM 3-ami-
nobenzamide, a condition that induces apoptosis [24]. It is
clear that these cells maintained their ability to exclude trypan
blue and displayed extensive blebbing as well as DNA frag-
mentation. Furthermore, under these conditions, the PACE
technique revealed the formation of DNA fragments 950 kb.
Taken together, these ¢ndings strongly suggest that tB-
OOH, under the experimental conditions utilized in this study,
does not elicit apoptosis but rather necrosis. Both pyruvate
and rotenone prevented this necrotic response and the cells
did not subsequently undergo apoptosis. Thus, the NADH-
linked substrate and the complex I inhibitor rescued the cells
from the toxic injury in£icted by tB-OOH.
This e¡ect was further explored by measuring the prolifer-
ation rate of cells treated for 30 min with 1 mM tB-OOH in a
glucose-free or -containing saline A and then post-incubated
for increasing time intervals in fresh growth medium. Under
these conditions, U937 cells exhibited a short lag period and
then grew in an exponential fashion for at least 48 h (Fig. 2).
As previously observed [18], glucose mitigated the lethal re-
sponse that was detected 6 h after exposure to tB-OOH. In
agreement with the above results, 5 mM pyruvate as well as
0.5 WM rotenone abolished the cell killing promoted by ex-
posure to hydroperoxide. Fig. 2 also shows that the cytopro-
tective e¡ect of the complex I inhibitor was concentration-
dependent over a range of 0.01^0.5 WM both in the presence
(A) or absence (B) of glucose. Interestingly, measurement of
the number of viable cells at increasing time intervals revealed
similar rates of proliferation in cells which survived the treat-
ment given by tB-OOH alone or associated with pyruvate or
rotenone, both in the absence (B) and presence (A) of glucose.
Taken together, these results demonstrate that pyruvate and
rotenone prevent the acute lethal response evoked by tB-OOH
and that cells surviving these treatments recover their ability
to proliferate. This would indicate that maintenance of
adequate intramitochondrial concentrations of NADH allows
the cells to fully recover from the insult generated by tB-
OOH.
The results illustrated in Fig. 3A indicate that the early
necrotic response evoked by tB-OOH is abolished by cyclo-
sporin A (0.5 WM). These cells, however, were unable to pro-
liferate and their number remained basically unchanged dur-
ing the 48 h of post-treatment growth (Fig. 3B). Since a few
dead cells (less than 10%) with the morphological features of
necrosis were occasionally found during this period (not
shown), it is reasonable to speculate that the net cell number
measured during the 48 h of post-challenge growth was the
result of proliferation of the undamaged cells and progressive
lysis of the damaged cells.
Thus, these results indicate that cyclosporin A prevents the
early necrotic response evoked by tB-OOH and that the cells
serving this treatment are either unable to proliferate or
undergo delayed death. As a consequence, prevention of
pore opening is a condition necessary and su⁄cient for abol-
ishing the acute lethal response evoked by tB-OOH, but nec-
essary and not su⁄cient for recovery of cell proliferation.
It is now well-established that many agents induce apopto-
sis or necrosis, depending on the severity of the insult in£icted
on the cells. The concept of the concentration-dependent in-
duction of apoptotic or necrotic cell death applies very well to
cells challenged with hydrogen peroxide. That H2O2 can trig-
ger apoptotic cell death has been clearly demonstrated in a
number of reports [25^28] and it is just as clear that the mode
of cell death switches from apoptosis to necrosis by increasing
the concentration of the oxidant. It may therefore be pre-
dicted that by reducing the extent of the insult, the opposite
may also occur. We recently demonstrated that the necrotic
response of U937 cells exposed to high concentrations of
H2O2 can also be prevented by inhibitors of poly(ADP-ribo-
se)polymerase via a mechanism which does not involve scav-
enging of reactive oxygen species or e¡ects on peroxide me-
tabolism [24]. Importantly, prevention of necrosis was
associated with a massive apoptotic response [24]. Thus, it is
reasonable to suggest that prevention of necrosis can be asso-
ciated with the onset of apoptosis both via mitigation of the
insult received by the cells and via interference with speci¢c
functions underlaying the necrotic response. The fact that an
increase in intramitochondrial NADH rescues the cells from
necrosis induced by tB-OOH and allows for the recovery of
functional competence and the ability to proliferate would
therefore indicate that this pyridine nucleotide promotes re-
pair of those lesions which may potentially lead the cells into
necrosis or apoptosis.
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